| Name | NU5455 |
|---|
| Description | NU5455 is a potent, selective, and orally active inhibitor of DNA-PKcs. NU5455 administration increases both the efficacy and the toxicity of a parenterally administered topoisomerase inhibitor. NU5455 enhances the activity of Doxorubicin released locally in liver tumor xenografts without inducing any adverse effect[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C34H33N3O5S |
|---|---|
| Molecular Weight | 595.71 |